Patent Application
20230024283
The present invention relates to novel herbicidal compounds, to processes for their preparation, to herbicidal compositions which comprise the novel compounds, and to their use for controlling weeds, in particular in crops of useful plants, or for inhibiting plant growth.
WO96/06089 teaches substituted biphenyl derivatives and their use as herbicides. It has now been found that certain intermediates that are described in the synthesis of the biphenyl derivatives therein are themselves herbicidal. Thus, according to the present invention there is provided a compound of Formula (I):
or an agronomically acceptable salt thereof,
wherein
X is CH or N,
R1 is selected from the group consisting of hydrogen, C1-C10alkylC(O)—, C1-C10alkylOC(O)—, C1-C10alkylSC(O)—and R5R6NC(O)—;
R2 is selected from the group consisting of halogen, NO2, CN, C1-C6haloalkylS(O)p—, C1-C6alkyl-S(O)p—, C2-C4alkenyl-, C2-C4alkynyl-, C1-C4haloalkyl and C1-C4haloalkoxy-;
R3 is selected from the group consisting of hydrogen, halogen, C1-C4alkyl, C1-C4haloalkyl, C1-C4alkoxy- and C1-C4haloalkoxy-;
R4 is phenyl or a five or six-membered heteroaryl, the heteroaryl containing from one to three heteroatoms each independently selected from the group consisting of oxygen, nitrogen and sulphur, and wherein the phenyl or heteroaryl may be optionally substituted by one or more substituents independently selected from the group consisting of halogen, C1-C6alkyl-, C2-C4alkenyl-, C2-C4alkynyl-, C1-C6haloalkyl-, C1-C6alkoxy-, C1-C6alkoxyC1C3-C3alkyl-, C1-C6alkoxyC1-C3alkoxy-, C1-C6haloalkoxy-, C1-C6alkyl-S(O)p—, C1-C6haloalkyl-S(O)p—, C3-C6cycloalkyl- (optionally substituted by 1 or 2 halogen), cyano and nitro; or
R4 is R4a
and
R5 is hydrogen or C1-C10alkyl;
R6 is hydrogen or C1-C10alkyl;
R7 and R8 are independently selected from the group consisting of hydrogen and halogen; and
p=0, 1 or 2;
wherein said compound is not selected from the group consisting of 2-(3-bromo-5-cyano-2-hydroxyphenyl)pyridine, 3-chloro-2-ethoxy-4-hydroxy-5-phenyl-benzonitrile, 4-hydroxy-3-nitro-5-[3-(trifluoromethyl)phenyl]benzonitrile and 2′-fluoro-6-hydroxy-5-nitrobiphenyl-3-carbonitrile.
C1-C4alkyl- includes, for example, methyl (Me, CH3), ethyl (Et, C2H5), n-propyl (n-Pr), isopropyl (i-Pr), n-butyl (n-Bu), isobutyl (i-Bu), sec-butyl and tert-butyl (t-Bu). C1-C2alkyl is methyl (Me, CH3) or ethyl (Et, C2H5).
Halogen (or halo) includes, for example, fluorine, chlorine, bromine or iodine. The same correspondingly applies to halogen in the context of other definitions, such as haloalkyl.
C1-C6haloalkyl- includes, for example, fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, 2,2,2-trifluoroethyl, 2-fluoroethyl, 2-chloroethyl, pentafluoroethyl, 1,1-difluoro-2,2,2-trichloroethyl, 2,2,3,3-tetrafluoropropyl and 2,2,2-trichloroethyl, heptafluoro-n-propyl and perfluoro-n-hexyl. C1-C4haloalkyl- and C1-C2haloalkyl include, for example, fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, 2,2,2-trifluoroethyl, 2-fluoroethyl, 2-chloroethyl, pentafluoroethyl, or 1,1-difluoro-2,2,2-trichloroethyl.
C1-C4alkoxy and C1-C2alkoxy includes, for example, methoxy and ethoxy.
C1-C6haloalkoxy- and C1-C4haloalkoxy- include, for example, fluoromethoxy, difluoromethoxy, trifluoromethoxy, 2,2,2-trifluoroethoxy, 1,1,2,2-tetrafluoroethoxy, 2-fluoroethoxy, 2-chloroethoxy, 2,2-difluoroethoxy or 2,2,2-trichloroethoxy, preferably difluoromethoxy, 2-chloroethoxy or trifluoromethoxy.
C2-C4alkenyl- includes, for example, —CH=CH2 (vinyl) and —CH2−CH=CH2 (allyl).
C2-C4alkynyl- refers to a straight or branched hydrocarbon chain radical group consisting solely of carbon and hydrogen atoms, containing at least one triple bond, having from two to four carbon atoms, and which is attached to the rest of the molecule by a single bond. Examples of C2-C4alkynyl include, but are not limited to, prop-1-ynyl, propargyl (prop-2-ynyl), and but-1-ynyl.
C1-C4alkyl-S— (alkylthio) includes, for example, methylthio, ethylthio, propylthio, isopropylthio, n-butylthio, isobutylthio, sec-butylthio or tert-butylthio, preferably methylthio or ethylthio.
C1-C4alkyl-S(O)— (alkylsulfinyl) includes, for example, methylsulfinyl, ethylsulfinyl, propylsulfinyl, isopropylsulfinyl, n-butylsulfinyl, isobutylsulfinyl, sec-butylsulfinyl or tert-butylsulfinyl, preferably methylsulfinyl or ethylsulfinyl.
C1-C4alkyl-S(O)2— (alkylsulfonyl) includes, for example, methylsulfonyl, ethylsulfonyl, propylsulfonyl, isopropylsulfonyl, n-butylsulfonyl, isobutylsulfonyl, sec-butylsulfonyl or tert-butylsulfonyl, preferably methylsulfonyl or ethylsulfonyl.
C3-C6alkyl- includes, for example, cyclopropyl and cyclohexyl.
Five or six-membered heteroaryl includes, for example, furanyl, thiophenyl, thiazolyl, oxazolyl, isoxazolyl, thiazolyl, pyrazolyl, isothiazolyl, oxadiazolyl, pyridyl, pyridazinyl, pyrazinyl, pyrimidinyl, thiadiazolyl and triazolyl.
In one embodiment of the present invention there is provided a compound of Formula (I) wherein R1 is C1-C6alkylC(O)— ( e.g CH3C(O)—, iPrC(O)—, t-butylC(O)—).
In another embodiment of the present invention there is provided a compound of Formula (I) wherein R1 is hydrogen.
In another embodiment of the present invention there is provided a compound of Formula (I) wherein R2 is selected from the group consisting of C1-C4haloalkyl, halogen and NO2, more preferably C1-C4haloalkyl (e.g C1-C4fluoroalkyl such as CF3, CF2H). In another preferred embodiment, R2 is selected from the group consisting of Br, Cl, CF2H, —CF3 and —OCF3, most preferably CF3.
In another embodiment of the present invention there is provided a compound of Formula (I) wherein R3 is selected from the group consisting of hydrogen, fluoro, chloro and methyl, most preferably hydrogen.
In another embodiment of the present invention there is provided a compound of Formula (I) wherein R4 is phenyl which is optionally substituted as outlined herein.
In another embodiment of the present invention there is provided a compound of Formula (I) wherein R4 a five or six-membered heteroaryl selected from the group consisting of furanyl, thiophenyl, thiazolyl, oxazolyl, isoxazolyl, thiazolyl, pyrazolyl, isothiazolyl, pyridyl, pyridazinyl, pyrazinyl, pyrimidinyl and triazolyl which is optionally substituted as defined herein. In a more preferred embodiment R4 is selected from the group consisting of phenyl, pyrazolyl (C or N linked), thiazolyl and thiophenyl which is optionally substituted as defined herein.
Where R4 is phenyl or a five or six-membered heteroaryl said phenyl or heteroaryl may be optionally substituted as described. For example, the phenyl or heteroaryl may comprise one, two, three or four substituents (depending on the nature of the heteroaryl). Where present, each substituent is preferably independently selected from the group consisting of halogen (e.g F, Cl), C1-C6haloalkyl- (e.g CF3, CF2H), C1-C6alkyl- (e.g methyl, ethyl), C3-C6cycloalkyl- (e.g cyclopropyl), cyano and C1-C6alkoxy- (e.g methoxy-, ethoxy-).
In another embodiment of the present invention R7 and R8 are independently selected from hydrogen and fluorine.
In another embodiment of the present invention there is provided a compound of Formula (I) wherein X is N.
In another embodiment of the present invention there is provided a compound of Formula (I) wherein X is CH.
Compounds of Formula (I) may contain asymmetric centres and may be present as a single enantiomer, pairs of enantiomers in any proportion or, where more than one asymmetric centre are present, contain diastereoisomers in all possible ratios. Typically one of the enantiomers has enhanced biological activity compared to the other possibilities.
The present invention also provides agronomically acceptable salts of compounds of Formula (I). Salts that the compounds of Formula (I) may form with amines, including primary, secondary and tertiary amines (for example ammonia, dimethylamine and triethylamine), alkali metal and alkaline earth metal bases, transition metals or quaternary ammonium bases are preferred.
The compounds of Formula (I) according to the invention can be used as herbicides by themselves, but they are generally formulated into herbicidal compositions using formulation adjuvants, such as carriers, solvents and surface-active agents (SAA). Thus, the present invention further provides a herbicidal composition comprising a herbicidal compound according to any one of the previous claims and an agriculturally acceptable formulation adjuvant. The composition can be in the form of concentrates which are diluted prior to use, although ready-to-use compositions can also be made. The final dilution is usually made with water, but can be made instead of, or in addition to, water, with, for example, liquid fertilisers, micronutrients, biological organisms, oil or solvents.
The herbicidal compositions generally comprise from 0.1 to 99% by weight, especially from 0.1 to 95% by weight, compounds of Formula I and from 1 to 99.9% by weight of a formulation adjuvant which preferably includes from 0 to 25% by weight of a surface-active substance.
The compositions can be chosen from a number of formulation types. These include an emulsion concentrate (EC), a suspension concentrate (SC), a suspo-emulsion (SE), a capsule suspension (CS), a water dispersible granule (WG), an emulsifiable granule (EG), an emulsion, water in oil (EO), an emulsion, oil in water (EW), a micro-emulsion (ME), an oil dispersion (OD), an oil miscible flowable (OF), an oil miscible liquid (OL), a soluble concentrate (SL), an ultra-low volume suspension (SU), an ultra-low volume liquid (UL), a technical concentrate (TK), a dispersible concentrate (DC), a soluble powder (SP), a wettable powder (WP) and a soluble granule (SG). The formulation type chosen in any instance will depend upon the particular purpose envisaged and the physical, chemical and biological properties of the compound of Formula (I).
Soluble powders (SP) may be prepared by mixing a compound of Formula (I) with one or more water-soluble inorganic salts (such as sodium bicarbonate, sodium carbonate or magnesium sulphate) or one or more water-soluble organic solids (such as a polysaccharide) and, optionally, one or more wetting agents, one or more dispersing agents or a mixture of said agents to improve water dispersibility/solubility. The mixture is then ground to a fine powder. Similar compositions may also be granulated to form water soluble granules (SG).
Wettable powders (WP) may be prepared by mixing a compound of Formula (I) with one or more solid diluents or carriers, one or more wetting agents and, preferably, one or more dispersing agents and, optionally, one or more suspending agents to facilitate the dispersion in liquids. The mixture is then ground to a fine powder. Similar compositions may also be granulated to form water dispersible granules (WG).
Granules (GR) may be formed either by granulating a mixture of a compound of Formula (I) and one or more powdered solid diluents or carriers, or from pre-formed blank granules by absorbing a compound of Formula (I) (or a solution thereof, in a suitable agent) in a porous granular material (such as pumice, attapulgite clays, fuller's earth, kieselguhr, diatomaceous earths or ground corn cobs) or by adsorbing a compound of Formula (I) (or a solution thereof, in a suitable agent) on to a hard core material (such as sands, silicates, mineral carbonates, sulphates or phosphates) and drying if necessary. Agents which are commonly used to aid absorption or adsorption include solvents (such as aliphatic and aromatic petroleum solvents, alcohols, ethers, ketones and esters) and sticking agents (such as polyvinyl acetates, polyvinyl alcohols, dextrins, sugars and vegetable oils). One or more other additives may also be included in granules (for example an emulsifying agent, wetting agent or dispersing agent).
Dispersible Concentrates (DC) may be prepared by dissolving a compound of Formula (I) in water or an organic solvent, such as a ketone, alcohol or glycol ether. These solutions may contain a surface active agent (for example to improve water dilution or prevent crystallisation in a spray tank).
Emulsifiable concentrates (EC) or oil-in-water emulsions (EW) may be prepared by dissolving a compound of Formula (I) in an organic solvent (optionally containing one or more wetting agents, one or more emulsifying agents or a mixture of said agents). Suitable organic solvents for use in ECs include aromatic hydrocarbons (such as alkylbenzenes or alkylnaphthalenes, exemplified by SOLVESSO 100, SOLVESSO 150 and SOLVESSO 200; SOLVESSO is a Registered Trade Mark), ketones (such as cyclohexanone or methylcyclohexanone) and alcohols (such as benzyl alcohol, furfuryl alcohol or butanol), N-alkylpyrrolidones (such as N-methylpyrrolidone or N-octylpyrrolidone), dimethyl amides of fatty acids (such as C8-C10 fatty acid dimethylamide) and chlorinated hydrocarbons. An EC product may spontaneously emulsify on addition to water, to produce an emulsion with sufficient stability to allow spray application through appropriate equipment.
Preparation of an EW involves obtaining a compound of Formula (I) either as a liquid (if it is not a liquid at room temperature, it may be melted at a reasonable temperature, typically below 70° C.) or in solution (by dissolving it in an appropriate solvent) and then emulsifying the resultant liquid or solution into water containing one or more SAAs, under high shear, to produce an emulsion. Suitable solvents for use in EWs include vegetable oils, chlorinated hydrocarbons (such as chlorobenzenes), aromatic solvents (such as alkylbenzenes or alkylnaphthalenes) and other appropriate organic solvents which have a low solubility in water.
Microemulsions (ME) may be prepared by mixing water with a blend of one or more solvents with one or more SAAs, to produce spontaneously a thermodynamically stable isotropic liquid formulation. A compound of Formula (I) is present initially in either the water or the solvent/SAA blend. Suitable solvents for use in MEs include those hereinbefore described for use in in ECs or in EWs. An ME may be either an oil-in-water or a water-in-oil system (which system is present may be determined by conductivity measurements) and may be suitable for mixing water-soluble and oil-soluble pesticides in the same formulation. An ME is suitable for dilution into water, either remaining as a microemulsion or forming a conventional oil-in-water emulsion.
Suspension concentrates (SC) may comprise aqueous or non-aqueous suspensions of finely divided insoluble solid particles of a compound of Formula (I). SCs may be prepared by ball or bead milling the solid compound of Formula (I) in a suitable medium, optionally with one or more dispersing agents, to produce a fine particle suspension of the compound. One or more wetting agents may be included in the composition and a suspending agent may be included to reduce the rate at which the particles settle. Alternatively, a compound of Formula (I) may be dry milled and added to water, containing agents hereinbefore described, to produce the desired end product.
Aerosol formulations comprise a compound of Formula (I) and a suitable propellant (for example n-butane). A compound of Formula (I) may also be dissolved or dispersed in a suitable medium (for example water or a water miscible liquid, such as n-propanol) to provide compositions for use in non-pressurised, hand-actuated spray pumps.
Capsule suspensions (CS) may be prepared in a manner similar to the preparation of EW formulations but with an additional polymerisation stage such that an aqueous dispersion of oil droplets is obtained, in which each oil droplet is encapsulated by a polymeric shell and contains a compound of Formula (I) and, optionally, a carrier or diluent therefor. The polymeric shell may be produced by either an interfacial polycondensation reaction or by a coacervation procedure. The compositions may provide for controlled release of the compound of Formula (I) and they may be used for seed treatment. A compound of Formula (I) may also be formulated in a biodegradable polymeric matrix to provide a slow, controlled release of the compound.
The composition may include one or more additives to improve the biological performance of the composition, for example by improving wetting, retention or distribution on surfaces; resistance to rain on treated surfaces; or uptake or mobility of a compound of Formula (I). Such additives include surface active agents (SAAs), spray additives based on oils, for example certain mineral oils or natural plant oils (such as soy bean and rape seed oil), modified plant oils such as methylated rape seed oil (MRSO), and blends of these with other bio-enhancing adjuvants (ingredients which may aid or modify the action of a compound of Formula (I).
Wetting agents, dispersing agents and emulsifying agents may be SAAs of the cationic, anionic, amphoteric or non-ionic type.
Suitable SAAs of the cationic type include quaternary ammonium compounds (for example cetyltrimethyl ammonium bromide), imidazolines and amine salts.
Suitable anionic SAAs include alkali metals salts of fatty acids, salts of aliphatic monoesters of sulphuric acid (for example sodium lauryl sulphate), salts of sulphonated aromatic compounds (for example sodium dodecylbenzenesulphonate, calcium dodecylbenzenesulphonate, butylnaphthalene sulphonate and mixtures of sodium di-isopropyl- and tri-isopropyl-naphthalene sulphonates), ether sulphates, alcohol ether sulphates (for example sodium laureth-3-sulphate), ether carboxylates (for example sodium laureth-3-carboxylate), phosphate esters (products from the reaction between one or more fatty alcohols and phosphoric acid (predominately mono-esters) or phosphorus pentoxide (predominately di-esters), for example the reaction between lauryl alcohol and tetraphosphoric acid; additionally these products may be ethoxylated), sulphosuccinamates, paraffin or olefine sulphonates, taurates, lignosulphonates and phosphates/sulphates of tristyrylphenols.
Suitable SAAs of the amphoteric type include betaines, propionates and glycinates.
Suitable SAAs of the non-ionic type include condensation products of alkylene oxides, such as ethylene oxide, propylene oxide, butylene oxide or mixtures thereof, with fatty alcohols (such as oleyl alcohol or cetyl alcohol) or with alkylphenols (such as octylphenol, nonylphenol or octylcresol); partial esters derived from long chain fatty acids or hexitol anhydrides; condensation products of said partial esters with ethylene oxide; block polymers (comprising ethylene oxide and propylene oxide); alkanolamides; simple esters (for example fatty acid polyethylene glycol esters); amine oxides (for example lauryl dimethyl amine oxide); lecithins and sorbitans and esters thereof, alkyl polyglycosides and tristyrylphenols.
Suitable suspending agents include hydrophilic colloids (such as polysaccharides, polyvinylpyrrolidone or sodium carboxymethylcellulose) and swelling clays (such as bentonite or attapulgite).
The herbicidal compounds of present invention can also be used in mixture with one or more additional herbicides and/or plant growth regulators. Examples of such additional herbicides or plant growth regulators include acetochlor, acifluorfen (including acifluorfen-sodium), aclonifen, ametryn, amicarbazone, aminopyralid, aminotriazole, atrazine, beflubutamid-M, bensulfuron (including bensulfuron-methyl), bentazone, bicyclopyrone, bilanafos, bispyribac-sodium, bixlozone, bromacil, bromoxynil, butachlor, butafenacil, carfentrazone (including carfentrazone-ethyl), cloransulam (including cloransulam-methyl), chlorimuron (including chlorimuron-ethyl), chlorotoluron, chlorsulfuron, cinmethylin, clacyfos, clethodim, clodinafop (including clodinafop-propargyl), clomazone, clopyralid, cyclopyranil, cyclopyrimorate, cyclosulfamuron, cyhalofop (including cyhalofop-butyl), 2,4-D (including the choline salt and 2-ethylhexyl ester thereof), 2,4-DB, desmedipham, dicamba (including the aluminium, aminopropyl, bis-aminopropylmethyl, choline, dichloroprop, diglycolamine, dimethylamine, dimethylammonium, potassium and sodium salts thereof) diclosulam, diflufenican, diflufenzopyr, dimethachlor, dimethenamid-P, diquat dibromide, diuron, ethalfluralin, ethofumesate, fenoxaprop (including fenoxaprop-P-ethyl), fenoxasulfone, fenquinotrione, fentrazamide, flazasulfuron, florasulam, florpyrauxifen (including florpyrauxifen-benzyl), fluazifop (including fluazifop-P-butyl), flucarbazone (including flucarbazone-sodium), flufenacet, flumetsulam, flumioxazin, fluometuron, flupyrsulfuron (including flupyrsulfuron-methyl-sodium), fluroxypyr (including fluroxypyr-meptyl), fomesafen, foramsulfuron, glufosinate (including the ammonium salt thereof), glyphosate (including the diammonium, isopropylammonium and potassium salts thereof), halauxifen (including halauxifen-methyl), haloxyfop (including haloxyfop-methyl), hexazinone, hydantocidin, imazamox, imazapic, imazapyr, imazethapyr, indaziflam, iodosulfuron (including iodosulfuron-methyl-sodium), iofensulfuron (including iofensulfuron-sodium), ioxynil, isoproturon, isoxaflutole, lancotrione, MCPA, MCPB, mecoprop-P, mesosulfuron (including mesosulfuron-methyl), mesotrione, metamitron, metazachlor, methiozolin, metolachlor, metosulam, metribuzin, metsulfuron, napropamide, nicosulfuron, norflurazon, oxadiazon, oxasulfuron, oxyfluorfen, paraquat dichloride, pendimethalin, penoxsulam, phenmedipham, picloram, pinoxaden, pretilachlor, primisulfuron-methyl, prometryne, propanil, propaquizafop, propyrisulfuron, propyzamide, prosulfocarb, prosulfuron, pyraclonil, pyraflufen (including pyraflufen-ethyl), pyrasulfotole, pyridate, pyriftalid, pyrimisulfan, pyroxasulfone, pyroxsulam, quinclorac, quinmerac, quizalofop (including quizalofop-P-ethyl and quizalofop-P-tefuryl), rimsulfuron, saflufenacil, sethoxydim, simazine, S-metalochlor, sulfentrazone, sulfosulfuron, tebuthiuron, tefuryltrione, tembotrione, terbuthylazine, terbutryn, tetflupyrolimet, thiencarbazone, thifensulfuron, tiafenacil, tolpyralate, topramezone, tralkoxydim, triafamone, triallate, triasulfuron, tribenuron (including tribenuron-methyl), triclopyr, trifloxysulfuron (including trifloxysulfuron-sodium), trifludimoxazin, trifluralin, triflusulfuron, ethyl 2-[[3-[2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenoxy]-2-pyridyl]oxy]acetate, 3-(2-chloro-4-fluoro-5-(3-methyl-2,6-dioxo-4-trifluoromethyl-3,6-dihydropyrimidin-1 (2H)-yl)phenyl)-5-methyl-4,5-dihydroisoxazole-5-carboxylic acid ethyl ester, 4-hydroxy-1-methoxy-5-methyl-3-[4-(trifluoromethyl)-2-pyridyl]imidazolidin-2-one, 4-hydroxy-1,5-dimethyl-3-[4-(trifluoromethyl)-2-pyridyl]imidazolidin-2-one, 5-ethoxy-4-hydroxy-1-methyl-3-[4-(trifluoromethyl)-2-pyridyl]imidazolidin-2-one, 4-hydroxy-1-methyl-3-[4-(trifluoromethyl)-2-pyridyl]imidazolidin-2-one, 4-hydroxy-1,5-dimethyl-3-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]imidazolidin-2-one, (4R)1-(5-tert-butylisoxazol-3-yl)-4-ethoxy-5-hydroxy-3-methyl-imidazolidin-2-one, 3-[2-(3,4-dimethoxyphenyl)-6-methyl-3-oxo-pyridazine-4-carbonyl]bicyclo[3.2.1]octane-2,4-dione, 2-[2-(3,4-dimethoxyphenyl)-6-methyl-3-oxo-pyridazine-4-carbonyl]-5-methyl-cyclohexane-1,3-dione, 2-[2-(3,4-dimethoxyphenyl)-6-methyl-3-oxo-pyridazine-4-carbonyl]cyclohexane-1,3-dione, 2-[2-(3,4-dimethoxyphenyl)-6-methyl-3-oxo-pyridazine-4-carbonyl]-5,5-dimethyl-cyclohexane-1,3-dione, 6-[2-(3,4-dimethoxyphenyl)-6-methyl-3-oxo-pyridazine-4-carbonyl]-2,2,4,4-tetramethyl-cyclohexane-1,3,5-trione, 2-[2-(3,4-dimethoxyphenyl)-6-methyl-3-oxo-pyridazine-4-carbonyl]-5-ethyl-cyclohexane-1,3-dione, 2-[2-(3,4-dimethoxyphenyl)-6-methyl-3-oxo-pyridazine-4-carbonyl]-4,4,6,6-tetramethyl-cyclohexane-1,3-dione, 2-[6-cyclopropyl-2-(3,4-dimethoxyphenyl)-3-oxo-pyridazine-4-carbonyl]-5-methyl-cyclohexane-1,3-dione, 3-[6-cyclopropyl-2-(3,4-dimethoxyphenyl)-3-oxo-pyridazine-4-carbonyl]bicyclo[3.2.1]octane-2,4-dione, 2-[6-cyclopropyl-2-(3,4-dimethoxyphenyl)-3-oxo-pyridazine-4-carbonyl]-5,5-dimethyl-cyclohexane-1,3-dione, 6-[6-cyclopropyl-2-(3,4-di methoxyphenyl)-3-oxo-pyridazi ne-4-carbonyl]-2,2,4,4-tetramethyl-cyclohexane-1,3,5-trione, 2-[6-cyclopropyl-2-(3,4-dimethoxyphenyl)-3-oxo-pyridazine-4-carbonyl]cyclohexane-1,3-dione, 4-[2-(3,4-dimethoxyphenyl)-6-methyl-3-oxo-pyridazine-4-carbonyl]-2,2,6,6-tetramethyl-tetrahydropyran-3,5-dione, 4-[6-cyclopropyl-2-(3,4-di methoxyphenyl)-3-oxo-pyridazine-4-carbonyl]-2,2,6,6-tetramethyl-tetrahydropyran-3,5-dione and 4-amino-3-chloro-5-fluoro-6-(7-fluoro-1H-indol-6-yl)pyridine-2-carboxylic acid (including agrochemically acceptable esters thereof, for example, methyl 4-amino-3-chloro-5-fluoro-6-(7-fluoro-1H-indol-6-yl))pyridine-2-carboxylate).
The mixing partners of the compound of Formula (I) may also be in the form of esters or salts, as mentioned e.g. in The Pesticide Manual, Sixteenth Edition, British Crop Protection Council, 2012.
The compound of Formula (I) can also be used in mixtures with other agrochemicals such as fungicides, nematicides or insecticides, examples of which are given in The Pesticide Manual.
The mixing ratio of the compound of Formula (I) to the mixing partner is preferably from 1:100 to 1000:1.
The mixtures can advantageously be used in the above-mentioned formulations (in which case “active ingredient” relates to the respective mixture of compound of Formula (I) with the mixing partner).
The compounds or mixtures of the present invention can also be used in combination with one or more herbicide safeners. Examples of such safeners include benoxacor, cloquintocet (including cloquintocet-mexyl), cyprosulfamide, dichlormid, fenchlorazole (including fenchlorazole-ethyl), fenclorim, fluxofenim, furilazole, isoxadifen (including isoxadifen-ethyl), mefenpyr (including mefenpyr-diethyl), metcamifen and oxabetrinil.
Particularly preferred are mixtures of a compound of Formula (I) with cyprosulfamide, isoxadifen-ethyl, cloquintocet-mexyl and/or metcamifen.
The safeners of the compound of Formula (I) may also be in the form of esters or salts, as mentioned e.g. in The Pesticide Manual, 16th Edition (BCPC), 2012. The reference to cloquintocet-mexyl also applies to a lithium, sodium, potassium, calcium, magnesium, aluminium, iron, ammonium, quaternary ammonium, sulfonium or phosphonium salt thereof as disclosed in WO 02/34048.
Preferably the mixing ratio of compound of Formula (I) to safener is from 100:1 to 1:10, especially from 20:1 to 1:1.
The present invention still further provides a method of controlling weeds at a locus said method comprising application to the locus of a weed controlling amount of a composition comprising a compound of Formula (I):
or an agronomically acceptable salt thereof,
wherein
X is CH or N,
R1 is selected from the group consisting of hydrogen, C1-C10alkylC(O)—, C1-C10alkylOC(O)—, C1-C10alkylSC(O)—and R5R6NC(O)—;
R2 is selected from the group consisting of halogen NO2, CN, C1-C6haloalkylS(O)p—, C1-C6alkyl-S(O)p—, C2-C4alkenyl-, C2-C4alkynyl-, C1-C4haloalkyl and C1-C4haloalkoxy-;
R3 is selected from the group consisting of hydrogen, halogen, C1-C4alkyl, C1-C4haloalkyl, C1-C4alkoxy- and C1-C4haloalkoxy-;
R4 is phenyl or a five or six-membered heteroaryl, the heteroaryl containing from one to three heteroatoms each independently selected from the group consisting of oxygen, nitrogen and sulphur, and wherein the phenyl or heteroaryl may be optionally substituted by one or more substituents selected from the group consisting of halogen, C1-C6alkyl-, C2-C4alkenyl-, C2-C4alkynyl-, C1-C6haloalkyl-, C1-C6alkoxy-, C1-C6alkoxyC1-C3alkyl-, C1-C6alkoxyC1-C3alkoxy-, C1-C6haloalkoxy-, C1-C6alkyl-S(O)p—, C1-C6haloalkyl-S(O)p—, C3-C6cycloalkyl- (optionally substituted by 1 or 2 halogen), cyano and nitro; or
R4 is R4a
and
R5 is hydrogen or C1-C10alkyl;
R6 is hydrogen or C1-C10alkyl;
R7 and R8 are independently selected from the group consisting of hydrogen and halogen; and
p=0, 1 or 2;
The present invention further relates to said method featuring preferred embodiments of compounds of Formula (I) referred to herein.
Moreover, the present invention may further provide a method of selectively controlling weeds at a locus comprising crop plants and weeds, wherein the method comprises application to the locus of a weed controlling amount of a composition according to the present invention. ‘Controlling’ means killing, reducing or retarding growth or preventing or reducing germination. It is noted that the compounds of the present invention show an improved selectivity compared to know, structurally similar compounds. Generally the plants to be controlled are unwanted plants (weeds). ‘Locus’ means the area in which the plants are growing or will grow. The application may be applied to the locus pre-emergence and/or postemergence of the crop plant. Some crop plants may be inherently tolerant to herbicidal effects of compounds of Formula (I). Preferred crop plants include maize, wheat, barley and rice.
The rates of application of compounds of Formula I may vary within wide limits and depend on the nature of the soil, the method of application (pre- or post-emergence; seed dressing; application to the seed furrow; no tillage application etc.), the crop plant, the weed(s) to be controlled, the prevailing climatic conditions, and other factors governed by the method of application, the time of application and the target crop. The compounds of Formula I according to the invention are generally applied at a rate of from 10 to 2500 g/ha, especially from 25 to 1000 g/ha, more especially from 25 to 250 g/ha.
The application is generally made by spraying the composition, typically by tractor mounted sprayer for large areas, but other methods such as dusting (for powders), drip or drench can also be used.
Crop plants are to be understood as also including those crop plants which have been rendered tolerant to other herbicides or classes of herbicides (e.g. ALS-, GS-, EPSPS-, PPO-, HPPD-, -PDS and ACCase-inhibitors) by conventional methods of breeding or by genetic engineering. An example of a crop that has been rendered tolerant to imidazolinones, e.g. imazamox, by conventional methods of breeding is Clearfield® summer rape (canola). Examples of crops that have been rendered tolerant to herbicides by genetic engineering methods include e.g. glyphosate- and glufosinate-resistant maize varieties commercially available under the trade names RoundupReady® and LibertyLink®.
Crop plants are also to be understood as being those which have been rendered resistant to harmful insects by genetic engineering methods, for example Bt maize (resistant to European corn borer), Bt cotton (resistant to cotton boll weevil) and also Bt potatoes (resistant to Colorado beetle). Examples of Bt maize are the Bt 176 maize hybrids of NK® (Syngenta Seeds). The Bt toxin is a protein that is formed naturally by Bacillus thuringiensis soil bacteria. Examples of toxins, or transgenic plants able to synthesise such toxins, are described in EP-A-451 878, EP-A-374 753, WO 93/07278, WO 95/34656, WO 03/052073 and EP-A-427 529. Examples of transgenic plants comprising one or more genes that code for an insecticidal resistance and express one or more toxins are KnockOutO (maize), Yield Gard® (maize), NuCOTIN33B® (cotton), Bollgard® (cotton), NewLeaf® (potatoes), NatureGard® and Protexcta®. Plant crops or seed material thereof can be both resistant to herbicides and, at the same time, resistant to insect feeding (“stacked” transgenic events). For example, seed can have the ability to express an insecticidal Cry3 protein while at the same time being tolerant to glyphosate.
Crop plants are also to be understood to include those which are obtained by conventional methods of breeding or genetic engineering and contain so-called output traits (e.g. improved storage stability, higher nutritional value and improved flavour).
The compositions can be used to control unwanted plants (collectively, ‘weeds’). The weeds to be controlled may be both monocotyledonous species, for example Agrostis, Alopecurus, Avena, Brachiaria, Bromus, Cenchrus, Cyperus, Digitaria, Echinochloa, Eleusine, Lolium, Monochoria, Rottboellia, Sagittaria, Scirpus, Setaria and Sorghum, and dicotyledonous species, for example Abutilon, Amaranthus, Ambrosia, Chenopodium, Chrysanthemum, Conyza, Galium, Ipomoea, Nasturtium, Sida, Sinapis, Solanum, Stellaria, Veronica, Viola and Xanthium.
The present invention further relates to the use of a compound of Formula (I):
or an agronomically acceptable salt thereof,
wherein
X is CH or N,
R1 is selected from the group consisting of hydrogen, C1-C10alkylC(O)—, C1-C10alkylOC(O)—, C1-C10alkylSC(O)—and R5R6NC(O)—;
R2 is selected from the group consisting of halogen NO2, CN, C1-C6haloalkylS(O)p—, C1-C6alkyl-S(O)p—, C2-C4alkenyl-, C2-C4alkynyl-, C1-C4haloalkyl and C1-C4haloalkoxy-;
R3 is selected from the group consisting of hydrogen, halogen, C1-C4alkyl, C1-C4haloalkyl, C1-C4alkoxy- and C1-C4haloalkoxy-;
R4 is phenyl or a five or six-membered heteroaryl, the heteroaryl containing from one to three heteroatoms each independently selected from the group consisting of oxygen, nitrogen and sulphur, and wherein the phenyl or heteroaryl may be optionally substituted by one or more substituents selected from the group consisting of halogen, C1-C6alkyl-, C2-C4alkenyl-, C2-C4alkynyl-, C1-C6haloalkyl-, C1-C6alkoxy-, C1-C6alkoxyC1-C3alkyl-, C1-C6alkoxyC1-C3alkoxy-, C1-C6haloalkoxy-, C1-C6alkyl-S(O)p—, C1-C6haloalkyl-S(O)p—, C3- C6cycloalkyl- (optionally substituted by 1 or 2 halogen), cyano and nitro; or
R4 is R4a
and
R5 is hydrogen or C1-C10alkyl;
R6 is hydrogen or C1-C10alkyl;
R7 and R8 are independently selected from the group consisting of hydrogen and halogen; and
p=0, 1 or 2;
as a herbicide.
The present invention further relates to said use featuring preferred embodiments of compounds of Formula (I) referred to herein.
The compounds of the present invention can be prepared according to the following general schemes.
(5-cyano-2-methoxy-phenyl)boronic acid can undergo cross-coupling with the desired aryl or heteroaryl halide (X can be I, Br, Cl) under palladium catalysis, employing a suitable palladium salt, ligand, base and solvent under elevated temperature. The resulting product is subjected to demethylation conditions, such as boron tribromide in a suitable solvent such as dichloromethane. The phenol can be halogenated with a suitable halogenating reagent such as N-bromosuccinimide at ambient or elevated temperatures, in a suitable solvent such as acetonitrile. The phenol can be further reacted with a range of acid chlorides, anhydrides or activated esters to afford the phenol esters.
Alternatively, the desired substituted phenol (Scheme 2) can be halogenated with a suitable halogenating reagent such as N-bromosuccinimide, either at ambient or elevated temperatures in a suitable solvent such as acetonitrile. The halogenated phenol can undergo cross-coupling with the desired aryl or heteroaryl boronic acid or ester, under palladium catalysis, employing a suitable palladium salt, ligand, base and solvent under elevated temperature (Path A). Where R2 is also a halogen, isomeric mixtures may result which can be separated by chromatography. These phenols can be further reacted with a range of acid chlorides, anhydrides or activated esters to afford the phenol esters. Alternatively, the halogenated phenol can be reacted with the desired acid chloride, anhydride or activated ester to afford the phenol esters (Path B). These intermediates can undergo cross-coupling with the desired aryl or heteroaryl boronic acid or ester, under palladium catalysis, employing a suitable palladium salt, ligand, base and solvent under elevated temperature to afford further compounds of the invention.
Alternatively, the desired substituted phenol (Scheme 3) can be halogenated with a suitable halogenating reagent such as N-bromosuccinimide, either at ambient or elevated temperatures in a suitable solvent such as acetonitrile. The halogenated phenol can then be protected with a suitable protecting group, such a benzyl or paramethoxybenzyl group, using benzyl chloride or paramethoxybenzylchloride, with a suitable base, such as potassium carbonate, in a suitable solvent such as acetone with a phase transfer catalyst such as tetrabutylammonium iodide. In a following step the bromide undergoes metalation with a Grignard reagent at low temperature in a suitable solvent such as THF. The resulting aryl Grignard is then reacted with a desired boronate, such as 2-ethoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane. The resulting aryl boronate can then be coupled to a range of aryl or heteroaryl halides in a Suzuki reaction, under elevated temperature, followed by deprotection, to afford further compounds of the invention.
A 25mL round bottomed flask was charged with a stirrer bar, (5-cyano-2-methoxy-phenyl)boronic acid (4.3 mmol, 0.76 g), 3-iodo-1-methyl-5-(trifluoromethyl)pyrazole (4 mmol, 1.10 g) and bis(triphenylphosphine)palladium dichloride (0.4 mmol, 0.28 g). Acetonitrile (10 mL) was added followed by and potassium carbonate (6 mmol, 0.82927 g) and mixture was heated at reflux. After 3 h, the reaction was diluted with dichloromethane (15 mL), washed with and brine (10 mL), dried with MgSO4 and concentrated. The crude product was then purified by chromatography (gradient elution EtOAc/Hexane) to afford 4-methoxy-3-[-1-methyl-5-(trifluoromethyl)pyrazol-3-yl]benzonitrile (665 mg, 60%) as an off white solid.
1HNMR (CDCl3) δ 8.28 (d, 1H), 7.51 (dd, 1H), 7.12 (s, 1H), 7.02 (1H, d), 5.04 (3H, s), 3.59 (3H, s).
To a solution of 4-methoxy-3-[-1-methyl-5-(trifluoromethyl)pyrazol-3-yl]benzonitrile (0.65 g, 2.312 mmol) in anhydrous dichloromethane (20 mL) at 0° C. and under nitrogen was added boron tribromide (1M solution in DCM) (8.090 mL, 8.090 mmol) dropwise. Once addition was complete, the reaction mixture was allowed to warm to room temperature and stirred for a further 2 h. The reaction was carefully quenched with water and then extracted with dichloromethane (3×10 mL). The organics were combined, washed with brine, dried over magnesium sulfate and concentrated in vacuo to afford 4-hydroxy-3-[-1-methyl-5-(trifluoromethyl)pyrazol-3-yl]benzonitrile yellow solid (600 mg, 97%).
1HNMR (CDCl3) δ 10.80 (s, 1H), 7.82 (d, 1H), 7.51 (dd, 1H), 7.09 (1H, d), 7.01 (1H, s), 4.08 (3H, s).
To a stirred solution of 4-hydroxy-3-[-1-methyl-5-(trifluoromethyl)pyrazol-3-yl]benzonitrile (0.580 g, 2.1706 mmol,) in acetonitrile (10 mL) was added 1-bromopyrrolidine-2,5-dione (0.579 g, 3.25 mmol), in one portion, and the mixture was heated at reflux for 2 h. The mixture was then diluted with EtOAc and washed with water (10 mL) and Brine (10), dried (MgSO4) and purified by chromatography to afford 3-bromo-4-hydroxy-5-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]benzonitrile (450 mg, 60%).
1HNMR (CDCl3) δ 11.59 (s, 1H), 7.80 (s, 1H), 7.36 (s, 1H), 7.03 (s, 1H), 4.09 (3H, s).
4,6-dibromo-5-hydroxy-pyridine-2-carbonitrile (1 g, 3.5984 mmol), dichloromethane (10 mL) N,N-diethylethanamine (1.2 equiv., 4.3181 mmol) were combined in a 50mL round bottomed flask and acetyl chloride (1.1 equiv., 3.9583 mmol) was added dropwise. After stirring at room temperature for 5 h, the mixture was washed with water (15 mL) and brine (15 mL), dried (MgSO4) and concentrated to afford a 2,4-dibromo-6-cyano-3-pyridyl) acetate 1.07g (93%).
1HNMR (CDCl3) δ 7.91 (s,1H), 2.46 (s, 3H).
(2,4-dibromo-6-cyano-3-pyridyl) acetate (0.2 g, 0.625 mmol), (3-fluorophenyl)boronic acid (87 mg 0.625 mmol,) and bis(triphenylphosphine)palladium(II)dichloride (22 mg, 0.031 mmol) were weighed into a microwave vial. Acetonitrile (5 mL) was added followed by a stirrer bar and sodium carbonate (1.2502 mmol). The vial was sealed and heated for 10 min at 130° C. in the microwave. The mixture was diluted with EtOAc (15 mL) and washed with 2M HCl (10 mL), and brine (10 mL), dried with MgSO4 and concentrated. The resulting crude product was purified by RPHPLC (to afford the separated isomers 4-bromo-6-(3-fluorophenyl)-5-hydroxy-pyridine-2-carbonitrile (15 mg) and 6-bromo-4-(3-fluorophenyl)-5-hydroxy-pyridine-2-carbonitrile (10 mg).
4-bromo-6-(3-fluorophenyl)-5-hydroxy-pyridine-2-carbonitrile 1HNMR (DMSO-d6) δ 8.31 (s,1H), 7.73 (t, 2H), 7.53 (q, 1H), 7.29 (td, 1H).
6-bromo-4-(3-fluorophenyl)-5-hydroxy-pyridine-2-carbonitrile 1HNMR (DMSO-d6) δ 7.98 (s,1H), 7.58-7.48 (m, 3H), 7.28-7.24 (m,1H).
3,5-dibromo-4-hydroxy-benzonitrile (5 g, 18.05 mmol) was weighed into a 250 ml round bottom flask and a stirrer bar added. Dichloromethane (100 mL) was added followed by triethylamine (1.1 equiv, 19.862 mmol) and the flask was cooled in an ice-bath. Acetyl chloride (1.1 equiv., 19.862 mmol) was added dropwise into the reaction mixture which was stirred for 1 h . The reaction mixture was washed with water (100ml×3) and the organic phase dried (MgSO4). The mixture was concentrated, in vacuo to afford the desired product (5.5 g, 96%).
1HNMR (CDCl3) δ 7.88 (s, 2H), 2.42 (s, 3H).
To a microwave tube, charged with a stirrer bar, was added (3-fluorophenyl)boronic acid (91 mg, 0.65 mmol), bis(triphenylphosphine)palladium (II) dichloride) (0.05 equiv., 0.0325 mmol), and (2,6-dibromo-4-cyano-phenyl) acetate (207 mg, 0.65 mmol) in acetonitrile (5 mL). A 1 molar solution of Sodium carbonate (2 eq. 1.3 mmol, 1.3 mL), was added and the tube was capped and microwaved at 150° C. for 15 mins. The reaction mixture was passed through a SiTMT SPE cartridge. The mixture was then concentrated in vacuo and the residue re-dissolved in 10% MeOH in DMSO and purified by mass directed RPHPLC to afford the 3-bromo-5-(3-fluorophenyl)-4-hydroxy-benzonitrile (32 mg, 15%).
1HNMR (CDCl3) δ 7.85 (d, 1H), 7.53 (1H, d), 7.50-7.46 (1H, m), 7.27-7.18 (3H, m), 6.20 (1H, bs).
To a stirred solution of 3-bromo-5-chloro-4-hydroxy-benzonitrile (0.100 g, 0.430 mmol) in anhydrous N,N-dimethylformamide (3.00 mL) , 4-(trifluoromethyl)-1H-pyrazole (0.0820 g, 0.602 mmol), Cesium carbonate (0.280 g, 0.860 mmol) and Copper iodide (0.0164 g, 0.0860 mmol) were added at RT. The reaction mixture was purged with nitrogen for 15 min and then heated at 120° C. in a sealed tube for 24 hrs. Then the reaction mass was diluted with EtOAc and passed through the bed of silica gel and concentrated to afford the crude product. Purification by chromatography, eluting with 0 to 20% EtOAc in hexane, affords 3-chloro-4-hydroxy-5-[4-(trifluoromethyl)pyrazol-1-yl]benzonitrile (10 mg, 8%).
1HNMR (400MHz,DMSO): δ 8.93 (s, 1H), 8.27 (s, 1H), 8.11-8.10 (m, 2H).
To a stirred solution of 4-hydroxy-3-(trifluoromethyl)benzonitrile (4.5 g, 24 mmol,) in acetonitrile (30 mL) was added N-bromosuccinimide (4.3 g, 24 mmol), in one portion, and the mixture was heated at reflux for 1.5 h. The mixture was allowed to cool to room temperature and then dry-loaded on silica and purified by chromatography using a EtOAc/cyclohexane gradient elution to afford 3-bromo-4-hydroxy-5-(trifluoromethyl)benzonitrile (6.4 g).
1H NMR (400 MHz, chloroform) δ ppm 7.99 (d, J=1.83 Hz, 1H) 7.85 (d, J=1.34 Hz, 1H) 6.34-6.90 (br s, 1H).
To a solution of 3-bromo-4-hydroxy-5-(trifluoromethyl)benzonitrile (6.4 g, 24 mmol) in acetone (64 mL) were added potassium carbonate (6.7 g, 48 mmol), tetrabutylammonium iodide (1.8 g, 4.8 mmol) and 1-(chloromethyl)-4-methoxy-benzene (5.7 g, 36 mmol). The reaction was heated at reflux. After 4 h the reaction was worked up with water and ethyl acetate were added and the phases separated. The organic phase was dried over magnesium sulphate and concentrated in vacuo. Purification by column chromatography (10% ethyl acetate in cyclohexane) afforded 3-bromo-4-[(4-methoxyphenyl)methoxy]-5-(trifluoromethyl)benzonitrile (77%, 7.18 g)
1H NMR (400 MHz, chloroform) δ ppm 8.05-8.15 (m, 1H) 7.90 (d, J=1.59 Hz, 1H) 7.40-7.54 (m, 2H) 6.91-6.99 (m, 2H) 5.09 (s, 2H) 3.84 (s, 3H).
To a stirring solution of 3-bromo-4-[(4-methoxyphenyl)methoxy]-5-(trifluoromethyl)benzonitrile (2.23 g, 5.77 mmol) and 2-isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (1.61 g, 8.66 mmol) in tetrahydrofuran (46.2 mL) at 0° C. was added isopropylmagnesium chloride Lithium chloride complex (1.3M in THF) (5.3 mL, 6.93 mmol) (added in a steady stream); after 45 min the reaction was quenched with sat. aq. ammonium chloride solution and extracted into ethyl acetate. The organic phase was dried over magnesium sulphate and concentrated in vacuo to afford a 3.4:1 ratio of 4-[(4-methoxyphenyl)methoxy]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethyl)benzonitrile and deborylated 4-[(4-methoxyphenyl)methoxy]-3-(trifluoromethyl)benzonitrile (3.13 g).
1H NMR (400 MHz, chloroform) δ ppm 8.24-8.34 (m, 1H) 7.93-8.05 (m, 1H) 7.43-7.48 (m, 2H) 6.90-6.95 (m, 2H) 5.09 (s, 2H) 3.83 (s, 3H) 1.39 (s, 12H).
2-bromothiazole (0.046 g, 0.28 mmol), 4-[(4-methoxyphenyl)methoxy]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethyl)benzonitrile (crude material, assumed ˜60% purity, 0.17 g, 0.24 mmol), SPhos Pd G3 (0.019 g, 0.024 mmol), tripotassium phosphate trihydrate (0.076 g, 0.35 mmol), cyclopentyl methyl ether (1.7 mL) and water (0.85 mL) were combined in a microwave vial. The vial was sealed and heated in the microwave at 120° C. for 10 mins. The sample was then diluted with water/ethyl acetate, the phases were separated, and the organic phase was dried over magnesium sulphate and concentrated in vacuo. 2,2,2-trifluoroacetic acid (0.5 mL) was added to the residue and the mixture was stirred for 5 min; water and ethyl acetate were added, the phases were separated and the organic phase was dried over magnesium sulphate and concentrated in vacuo. The cured mixture was purified by RPHPLC to afford 4-hydroxy-3-thiazol-2-yl-5-(trifluoromethyl)benzonitrile (0.0142 g, 22%).
1H NMR (400 MHz, chloroform) δ ppm 8.11 (d, J=1.96 Hz, 1H) 7.92 (d, J=3.42 Hz, 1H) 7.89 (d, J=1.34 Hz, 1H) 7.50 (d, J=3.30 Hz, 1H)
The following tables provide examples of herbicidal compounds of the present invention. Mass spectrometry data was collected on a Waters Acquity UPLC-MS using a Sample Organizer with Sample Manager FTN, H-Class QSM, Column Manager, 2× Column Manager Aux, Photodiode Array (Wavelength range (nm): 210 to 400), ELSD and QDa mass spectrometer. Ionisation method: Electrospray positive and negative: Cone (V) 20.00, Source Temperature (° C.) 120, Cone Gas Flow (L/Hr.) 50. Mass range (Da): positive 100 to 800, negative 115 to 800.
Method 1) analysis was conducted using a four-minute run time, according to the following gradient table at 40° C.:
Waters Acquity UPLC HSS T3 (1.8 μm 2.1×50 mm).
Solvent A: H2O with 0.05% TFA Solvent B: CH3CN with 0.05% TFA
Method 2) Analysis was conducted using a two-minute run time, according to the following gradient table at 40° C.:
Waters Acquity UPLC HSS T3 (1.8 μm 2.1×30 mm).
Solvent A: H2O with 0.05% TFA Solvent B: CH3CN with 0.05% TFA
1HNMR
1HNMR
Seeds of a variety of test species are sown in standard soil in pots (Ipomoea hederacea (IPOHE), Abutilon theophrasti (ABUTH), Amaranthus retoflexus (AMARE), Echinochloa crus-galli (ECHCG), Setaria faberi (SETFA)). After 8 days cultivation under controlled conditions in a glasshouse (at 24/16° C., day/night; 14 hours light; 65% humidity), the plants are sprayed with an aqueous spray solution derived from the formulation of the technical active ingredient in acetone / water (50:50) solution containing 0.5% Tween 20 (polyoxyethelyene sorbitan monolaurate, CAS RN 9005-64-5). Compounds are applied at 1000 g/ha unless otherwise stated. The test plants are then grown in a glasshouse under controlled conditions in a glasshouse (at 24/16° C., day/night; 14 hours light; 65% humidity) and watered twice daily. After 13 days the test is evaluated for the percentage damage caused to the plant. The biological activities are shown in the following table on a five-point scale (5=81-100%; 4=61-80%; 3=41-60%; 2=21-40%; 1=0-20%).
| Number | Date | Country | Kind |
|---|---|---|---|
| 2000011.3 | Jan 2020 | GB | national |
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/EP2020/087853 | 12/24/2020 | WO |
